Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel E. Sherman, M.D.

Concepts (54)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
United States Food and Drug Administration12201816012.010 Why?
Drug Approval520177951.310 Why?
Drug and Narcotic Control220171411.270 Why?
Investigational New Drug Application22015171.220 Why?
Clinical Trials as Topic5201778820.710 Why?
Orphan Drug Production12017600.680 Why?
Computer Communication Networks120183090.670 Why?
Device Approval220171830.630 Why?
Prescription Fees120161550.620 Why?
Adverse Drug Reaction Reporting Systems220184650.620 Why?
Drugs, Investigational220152310.580 Why?
Drug Design2201711570.560 Why?
Government Regulation320165470.500 Why?
Evidence-Based Practice120164790.480 Why?
Informed Consent120159400.390 Why?
Comparative Effectiveness Research120126630.340 Why?
Qualitative Research1201220890.290 Why?
Health Policy1201625370.280 Why?
Evidence-Based Medicine1201637230.270 Why?
United States142018618760.260 Why?
Patient Selection1201542970.250 Why?
Product Surveillance, Postmarketing220184640.220 Why?
Delivery of Health Care1201641110.200 Why?
Interinstitutional Relations120162690.150 Why?
Public Sector120172590.150 Why?
Forms and Records Control120141630.130 Why?
Rare Diseases120174530.130 Why?
Research Design3201655890.110 Why?
Endpoint Determination120146330.110 Why?
Equipment Design1201736150.090 Why?
Time Factors32017414510.090 Why?
Databases, Factual2201273310.080 Why?
Pharmaceutical Preparations120148130.080 Why?
Prescription Drugs120125500.080 Why?
Decision Making2201638010.080 Why?
Humans1320186483300.070 Why?
Biomedical Research1201630990.060 Why?
Randomized Controlled Trials as Topic2201488710.050 Why?
Consumer Product Safety120161370.040 Why?
Registries1201274510.040 Why?
Clinical Trials Data Monitoring Committees12014270.040 Why?
Efficiency, Organizational120177310.030 Why?
Sample Size120127500.020 Why?
Equipment and Supplies120122840.020 Why?
National Institutes of Health (U.S.)120127380.020 Why?
Research Support as Topic120127600.020 Why?
Retrospective Studies12014613510.020 Why?
Biological Products120126100.020 Why?
Drug Industry120128850.020 Why?
Communication1201430120.010 Why?
Pilot Projects1201274520.010 Why?
Mental Disorders1201261300.010 Why?
Cardiovascular Diseases12012125050.010 Why?
Neoplasms12012182440.000 Why?
Sherman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (54)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.